Home > Income Statement > SUDARSHAN PHARMA INDUSTRIES

SUDARSHAN PHARMA INDUSTRIES
Revenue

    Back to Income Statement
SUDARSHAN PHARMA INDUSTRIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SUDARSHAN PHARMA INDUSTRIES
Please provide your vote to see the results

SUDARSHAN PHARMA INDUSTRIES Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹505 Cr₹464 Cr₹461 Cr₹357 Cr₹193 Cr

What is the latest Revenue of SUDARSHAN PHARMA INDUSTRIES ?

The latest Revenue ratio of SUDARSHAN PHARMA INDUSTRIES is ₹505 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹505 Cr
Mar2024₹464 Cr
Mar2023₹461 Cr
Mar2022₹357 Cr
Mar2021₹193 Cr

How is Revenue of SUDARSHAN PHARMA INDUSTRIES Trending?

Years Revenue % Change
Mar2025 ₹505 Cr
8.95
Mar2024 ₹464 Cr
0.48
Mar2023 ₹461 Cr
29.19
Mar2022 ₹357 Cr
84.69
Mar2021 ₹193 Cr -

Compare Revenue of peers of SUDARSHAN PHARMA INDUSTRIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUDARSHAN PHARMA INDUSTRIES ₹849.0 Cr -5.6% -15.3% 20% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹467,630.0 Cr -0.1% 0.5% 14% Stock Analytics
DIVIS LABORATORIES ₹218,972.0 Cr -0.9% 21.1% 25.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹188,358.0 Cr -1.3% 1.1% 32.7% Stock Analytics
CIPLA ₹118,916.0 Cr 0.2% 2.1% -5.1% Stock Analytics
DR REDDYS LABORATORIES ₹97,824.0 Cr 0.2% -7.7% -7.5% Stock Analytics


SUDARSHAN PHARMA INDUSTRIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SUDARSHAN PHARMA INDUSTRIES

-5.6%

-15.3%

20%

SENSEX

0.5%

2.6%

-3.7%


You may also like the below Video Courses